Chromatography Columns Market Summary
As per Market Research Future Analysis, the Global Chromatography Columns Market was valued at USD 13.32 Billion in 2023 and is projected to grow to USD 22.06 Billion by 2032, with a CAGR of 5.78% from 2024 to 2032. Key drivers include rising life science R&D costs, increased demand for biopharmaceuticals, and growth in monoclonal antibody manufacturing. The market is supported by government initiatives and investments in advanced chromatographic techniques, particularly in the pharmaceutical and biotechnology sectors.
Key Market Trends & Highlights
The chromatography columns market is experiencing significant growth driven by various factors.
- Market Size in 2023: USD 13.32 Billion; Projected Market Size by 2032: USD 22.06 Billion.
- CAGR from 2024 to 2032: 5.78%; Dominant Segment: Prepacked Chromatography Columns.
- North America accounted for USD 5.72 Billion in 2022, holding around 45.80% market share.
- Pharmaceutical Biotechnology Companies are the fastest-growing end-user segment during the forecast period.
Market Size & Forecast
2023 Market Size | USD 13.32 Billion |
2024 Market Size | USD 14.07 Billion |
2032 Market Size | USD 22.06 Billion |
CAGR (2024-2032) | 5.78% |
Major Players
Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Agilent Technologies Inc. (US), Daicel Corporation (Japan), Shimadzu Corporation (Japan), PerkinElmer Inc. (US), Bio-Rad Laboratories Inc. (US), Biotage (Sweden), Waters (US), KNAUER WissenschaftlicheGeräte GmbH (Germany), Tosoh Corporation (Japan)